Sensitive Pharmaceutical Topics in China: What to Avoid Discussing

In China, certain pharmaceutical topics are politically and regulatorily sensitive. Public discussion without deep contextual understanding risks regulatory scrutiny, censorship, or legal consequences.

Key Sensitive Areas

• Price transparency: Government tightly controls drug pricing; companies cannot publicly disclose specific prices/discounts.
• International price comparisons: Discouraged to avoid trade disputes and perception of higher domestic pricing.
• Government policies/regulations: Criticism or analysis may be seen as undermining authority.
• Corruption: Public discussion of pharma corruption cases is discouraged, hindering systemic reform.
• Controversial ingredients/side effects: Negative publicity on safety/efficacy can trigger severe regulatory and commercial repercussions.

These sensitivities stem from complex government-industry-public dynamics. Exercise extreme caution in public forums.